Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
4.360
-0.190 (-4.18%)
Mar 31, 2025, 10:46 AM EDT - Market open
Health Catalyst Analyst Ratings
Total Analysts
11
Consensus Rating
Buy
Price Target
$9.27
Upside
+112.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | +14.68% | Mar 6, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +37.61% | Feb 27, 2025 |
| Stifel | Stifel | Hold Maintains $10 → $5 | Hold | Maintains | $10 → $5 | +14.68% | Feb 27, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $7 | Hold | Reiterates | $7 | +60.55% | Feb 27, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $8 | Buy | Maintains | $12 → $8 | +83.49% | Feb 11, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $13 → $10 | Buy | Maintains | $13 → $10 | +129.36% | Jan 21, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +129.36% | Jan 21, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | +60.55% | Jan 15, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +129.36% | Jan 10, 2025 |
| Keybanc | Keybanc | Hold → Buy Upgrades $9 | Hold → Buy | Upgrades | $9 | +106.42% | Jan 8, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $11 → $12 | Buy | Reiterates | $11 → $12 | +175.23% | Nov 26, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $7 → $9 | Hold | Maintains | $7 → $9 | +106.42% | Nov 14, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +140.83% | Nov 13, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +106.42% | Nov 7, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +129.36% | Oct 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $16 | Buy | Reiterates | $16 | +266.97% | Oct 4, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.